Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Talaris Therapeutics (TALS) Insider Trading & Ownership

Talaris Therapeutics logo

Talaris Therapeutics (NASDAQ:TALS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.50%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$2.18M
Get TALS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Talaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TALS Insider Buying and Selling by Quarter

Talaris Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2023Suzanne IldstadDirectorSell12,942$2.49$32,225.58  
6/12/2023Suzanne IldstadDirectorSell16,870$2.59$43,693.30  
6/9/2023Suzanne IldstadDirectorSell25,419$2.46$62,530.74  
6/7/2023Suzanne IldstadDirectorSell75,001$2.39$179,252.39  
6/5/2023Suzanne IldstadDirectorSell7,841$2.52$19,759.32  
6/1/2023Suzanne IldstadDirectorSell15,713$2.56$40,225.28  
4/21/2023Suzanne IldstadDirectorSell15,004$2.35$35,259.40  
4/19/2023Suzanne IldstadDirectorSell21,753$2.16$46,986.48  
4/17/2023Suzanne IldstadDirectorSell99,771$2.14$213,509.94  
3/17/2023Suzanne IldstadDirectorSell10,436$2.06$21,498.16  
3/1/2023Suzanne IldstadDirectorSell29$2.05$59.45  
2/21/2023Suzanne IldstadDirectorSell3,500$2.05$7,175.00  
2/16/2023Suzanne IldstadDirectorSell2,939$2.06$6,054.34  
8/22/2022Suzanne IldstadInsiderSell525,000$2.80$1,470,000.00  
(Data available from 1/1/2013 forward)

TALS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Talaris Therapeutics includes Suzanne Ildstad. Learn more on insiders at TALS.

16.50% of Talaris Therapeutics stock is owned by insiders. Learn more on TALS's insider holdings.



This page (NASDAQ:TALS) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners